Clinical Research Directory
Browse clinical research sites, groups, and studies.
Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.
Sponsor: Istituto Clinico Humanitas
Summary
Italian multicentric non inferiority clinical study to verify whether the omission of axillary lymph node intervention in patients with SLN (Sentinel Lymph Nodes) ypN1mi after NAC (Neo Adiuvant Chemotherapy) does not lead to a significant deterioration in survival or in the risk of regional or distant recurrence, compared to patients with negative SLN (SLN ypN0) after NAC ,where the omission of axillary treatment is currently the standard treatment.
Official title: Breast Carcinoma T1-T2-T3 / cN +: Axillary Conservation of Lymph Nodes in the Presence of Micro Metastases in Sentinel Lymph Node, in cN- After Neoadjuvant Chemotherapy - Studio NEONOD 2
Key Details
Gender
FEMALE
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
850
Start Date
2019-06-21
Completion Date
2027-06-21
Last Updated
2021-04-19
Healthy Volunteers
No
Conditions
Interventions
Omission of Axillary dissection
In Group 1 and 2: Axillary dissection won't be performed
Locations (1)
Istituto Clinico Humanitas
Rozzano, MI, Italy